# Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes

> **NCT04053621** · NA · UNKNOWN · sponsor: **Laboratorios Manuell SA** · enrollment: 92 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** Thiamine pyrophosphate
- **OTHER:** Placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04053621
- **Lead sponsor:** Laboratorios Manuell SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-03
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053621, "Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04053621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*